Oncology / Hematology

Study from Japan shows pandemic impact on some cancers, not others A study from Japan is among the first to show significant increases in later stage compared to early stage colorectal cancers identified during the Covid-19...

KEYNOTE-716 findings support post-surgery pembrolizumab Patients diagnosed with high-risk melanoma who are treated with adjuvant pembrolizumab after surgery appear to have a significantly reduced risk of recurrence of the...

But nivolumab/ipilimumab combo added to chemo does not improve survival Updated results of the CheckMate 649 study confirmed that adding nivolumab to chemotherapy among patients diagnosed with gastric cancers appears to improve...

Head-to-head trial found 72% reduction in risk of progression A potent antibody-drug conjugate (ADC) approved for treatment of breast cancer—trastuzumab deruxtecan—was clearly more effective in treating...